SOPHiA GENETICS S.A.
SOPHiA GENETICS S.A. (SOPH) Revenue
Annual & quarterly revenue history · segment & region breakdown
SOPH · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsSOPHiA GENETICS S.A. trailing twelve-month (TTM) revenue is $0.08B, an increase of 18.56% year-over-year from $0.08B in FY2025.
Revenue trend
2025 – 2019 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.08B | +$0.01B | +18.56% |
| 2024-12-31 | $0.07B | +$0.00B | +4.49% |
| 2023-12-31 | $0.06B | +$0.01B | +31.14% |
| 2022-12-31 | $0.05B | +$0.01B | +17.58% |
| 2021-12-31 | $0.04B | +$0.01B | +42.43% |
| 2020-12-31 | $0.03B | +$0.00B | +11.98% |
| 2019-12-31 | $0.03B | — | — |
Compare revenue vs peers
Medical - Healthcare Information ServicesCompare SOPH revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income SOPHiA GENETICS S.A. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
SOPHiA GENETICS S.A. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from SOPHiA GENETICS S.A.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
SOPH revenue · 4 questionsSOPH's trailing twelve-month (TTM) revenue is $0.08B. That is an increase of 18.56% year-over-year from $0.08B in FY2025.
▸ Source: FMP · SOPHiA GENETICS S.A. SEC filings · GAAP · SOPHiA GENETICS S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026